Polyrizon Ltd
PLRZ
查看详细走势图
9.430USD
-0.680-6.73%
收盘 12/19, 16:00（美东）报价延迟15分钟
55.46M总市值
亏损市盈率 TTM
盘中分时
1分
30分
1小时
日k
周k
月k
日k
今天
-6.73%
5天
-25.22%
1月
+147.16%
6月
+115.59%
今年开始到现在
-99.71%
1年
-99.60%
查看详细走势图
TradingKey Polyrizon Ltd股票评分
单位: USD 更新时间: 2025-10-27操作建议
当前估值合理，机构持股占比非常高，目前股价在压力位和支撑位之间，可以做区间波段操作。
Polyrizon Ltd评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
分析师目标
根据
0
位分析师
--
评级
0.000
目标均价
0.00%
涨幅空间
数据免责声明：分析师评级与目标价由LSEG提供，仅供参考，不应当作投资建议
Polyrizon Ltd亮点
亮点风险
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
利润高增长
公司净利润处于行业前列，最新年度总收入0.00美元
估值合理
公司最新PE估值-2.14，处于3年历史合理位
机构加仓
最新机构持股370.57K股，环比增加49.99%
Polyrizon Ltd新闻
即将为您带来更多新闻，敬请期待。。。
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Polyrizon Ltd简介
Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
公司代码PLRZ
公司Polyrizon Ltd
CEOIzraeli (Tomer)
网址https://polyrizon-biotech.com/
常见问题
Polyrizon Ltd(PLRZ)的当前股价是多少？
Polyrizon Ltd(PLRZ)的当前股价是 9.430。
Polyrizon Ltd的股票代码是什么？
Polyrizon Ltd的股票代码是PLRZ。
Polyrizon Ltd股票的52周最高点是多少？
Polyrizon Ltd股票的52周最高点是4590.000。
Polyrizon Ltd股票的52周最低点是多少？
Polyrizon Ltd股票的52周最低点是2.880。
Polyrizon Ltd的市值是多少？
Polyrizon Ltd的市值是55.46M。
Polyrizon Ltd的净利润是多少？
Polyrizon Ltd的净利润为-1.60M。
现在Polyrizon Ltd(PLRZ)的股票是买入、持有还是卖出？
根据分析师评级，Polyrizon Ltd(PLRZ)的总体评级为--，目标价格为--。
Polyrizon Ltd(PLRZ)股票的每股收益（EPS TTM）是多少
Polyrizon Ltd(PLRZ)股票的每股收益（EPS TTM）是-97.075。
相关品种
